Top Markets
Coin of the day
MetaStat Inc MetaStat Inc

MetaStat Inc

MTST
Peringkat dalam Saham #42020
MetaStat, Inc., a precision medicine company, focuses on discovering and... MetaStat, Inc., a precision medicine company, focuses on discovering and developing therapeutic and diagnostic treatment solutions for cancer patients. The company is developing novel drug candidates and companion diagnostic tests that target the MENA pathway. Its product candidates include MENA diagnostic assay, a tissue-based quantitative immunofluorescence test that measures expression of the pro-metastatic MENA protein splice-variant; companion diagnostic to predict RTK inhibitor drug responses and anti-microtubule drug responses; liquid blood-based biopsy to enhance cancer diagnosis and optimize patient care; MetaSite Breast assay, an immunohistochemistry test that measures micro-anatomical intravasat at blood vessels within the tumor microenvironment ion sites; and prognostic diagnostic to predict risk of cancer metastasis. The company’s therapeutic targets a critical metastatic pathway in solid tumors responsible for driving tumor resistance and the spread of aggressive cancer. MetaStat, Inc. is based in Boston, Massachusetts.
Harga Saham
$0.001
Terakhir disinkronkan: 2026-08-11
Kapitalisasi Pasar
$5.88K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
400.00%
Negara
US
Perdagangan MetaStat Inc (MTST)

Kategori

EPS untuk MetaStat Inc (MTST)
EPS per 2026 TTM: 0
Menurut laporan keuangan terbaru dan harga saham MetaStat Inc, EPS perusahaan saat ini (TTM) adalah 0. Pada akhir 2026, perusahaan memiliki EPS sebesar 0 sama dengan EPS tahun 2026 sebesar 0.
Riwayat EPS untuk MetaStat Inc dari 2026 hingga 2026
EPS di akhir setiap tahun
Tahun EPS Mengubah
Tidak cukup data untuk tanggal yang disediakan.
EPS untuk perusahaan sejenis atau pesaing